TRAIL resistance in a range of cancer cells is likely due to a combination of multiple factors including lack of surface DR4 or DR5 that trigger DR-mediated apoptosis as well as elevated anti-apoptotic proteins and/or the absence of pro-apoptotic proteins that play key roles in TRAIL resistance and sensitization, respectively. The gene discussed is TNFSF10; the disease is cancer.